Advanced company searchLink opens in new window

FORCEFIELD THERAPEUTICS LIMITED

Company number 12983133

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
14 Nov 2024 CS01 Confirmation statement made on 28 October 2024 with updates
12 Oct 2024 AA Accounts for a small company made up to 31 December 2023
12 Jul 2024 AP01 Appointment of Dr David William Evans as a director on 17 June 2024
11 Jul 2024 MA Memorandum and Articles of Association
11 Jul 2024 SH08 Change of share class name or designation
11 Jul 2024 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES10 ‐ Resolution of allotment of securities
09 Jul 2024 SH01 Statement of capital following an allotment of shares on 17 June 2024
  • GBP 90.6267
08 Jul 2024 TM01 Termination of appointment of Mauro Giacca as a director on 17 June 2024
17 Apr 2024 SH08 Change of share class name or designation
12 Apr 2024 SH01 Statement of capital following an allotment of shares on 28 March 2024
  • GBP 69.70715
08 Apr 2024 MA Memorandum and Articles of Association
08 Apr 2024 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES10 ‐ Resolution of allotment of securities
29 Dec 2023 AA Accounts for a small company made up to 31 December 2022
09 Nov 2023 CS01 Confirmation statement made on 28 October 2023 with updates
13 Sep 2023 SH10 Particulars of variation of rights attached to shares
13 Sep 2023 SH08 Change of share class name or designation
13 Sep 2023 SH08 Change of share class name or designation
05 Sep 2023 SH01 Statement of capital following an allotment of shares on 18 August 2023
  • GBP 63.04049
01 Aug 2023 AP01 Appointment of Dr Elisa Petris as a director on 27 June 2023
01 Aug 2023 AP01 Appointment of Dr John Tsai as a director on 27 June 2023
01 Aug 2023 TM01 Termination of appointment of Christopher John Hollowood as a director on 27 June 2023
17 Apr 2023 TM01 Termination of appointment of Richard David Francis as a director on 31 December 2022
09 Nov 2022 CS01 Confirmation statement made on 28 October 2022 with no updates
17 Oct 2022 RP04CS01 Second filing of Confirmation Statement dated 31 January 2022
10 Oct 2022 SH01 Statement of capital following an allotment of shares on 18 June 2021
  • GBP 33.04049